Skip to main content
Livermore
Livermore
ZHEN

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Aug 17, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
148
+12 vs. Q1 2021
Portfolio value
$7.69B
+$165.9M (+2.2%) vs. Q1 2021
Filed
Aug 17, 2021
AmendedSEC
Holdings of Perceptive Advisors LLC in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
CYPHCypherpunk Technologies Inc.COM8,476,496$13.9M0.2%00.0%UnchangedHistory
HRMYHarmony Biosciences Holdings, Inc.COM491,332$13.9M0.2%+179,659+57.6%AddedHistory
CM Life Sciences III Inc125841205UNIT 04/30/20281,250,000$13.7M0.2%+1,250,000New–
ACCDAccolade, Inc.COM245,741$13.3M0.2%−100,000−28.9%ReducedHistory
CVRXCVRx, Inc.COM440,000$12.3M0.2%+440,000NewHistory
BCLS Acquisition CorpG0904B105COM CL A1,000,000$10.5M0.1%00.0%Unchanged–
CTMXCytomX Therapeutics, Inc.COM1,640,957$10.4M0.1%−513,017−23.8%ReducedHistory
RACBResearch Alliance Corp. IICOM CL A1,000,000$10.1M0.1%00.0%UnchangedHistory
Summit Healthcre Acquistn CoG8566R128UNIT 06/03/20261,000,000$10.0M0.1%+1,000,000New–
TBIOTelesis Bio Inc.COM425,000$9.35M0.1%+425,000NewHistory
CNCEConcert Pharmaceuticals, Inc.COM2,150,641$9.07M0.1%00.0%UnchangedHistory
FDMT4D Molecular Therapeutics, Inc.COM375,256$9.04M0.1%−69,622−15.6%ReducedHistory
PRVBProvention Bio, Inc.COM948,481$8.00M0.1%−1,903,577−66.7%ReducedHistory
PSTXPoseida Therapeutics, Inc.COM787,745$7.89M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS755,375$7.39M0.1%00.0%Unchanged–
SILKSilk Road Medical IncCOM147,133$7.04M0.1%−192,967−56.7%ReducedHistory
DRIODarioHealth Corp.COM NEW327,869$7.00M0.1%00.0%UnchangedHistory
TSHATaysha Gene Therapies, Inc.COM SHS320,440$6.79M0.1%−150,000−31.9%ReducedHistory
PRVAPrivia Health Group, Inc.COM135,000$5.99M0.1%+135,000NewHistory
AKYAAkoya Biosciences, Inc.COM300,000$5.80M0.1%+300,000NewHistory
BCTG Acquisition Corp05492W103COM500,000$5.69M0.1%00.0%Unchanged–
MREOMereo BioPharma Group plcSPON ADS1,696,068$5.38M0.1%−4,303,932−71.7%ReducedHistory
Consonance HFW Acquisition CG2445M129UNIT 99/99/9999500,000$5.20M0.1%00.0%Unchanged–
PRTAProthena Corp Public Ltd CoSHS100,000$5.14M0.1%+100,000NewHistory
Longview Acquisition Corp. II54319Q204UNIT 99/99/9999500,000$5.04M0.1%00.0%Unchanged–
OBIOOrchestra BioMed Holdings, Inc.ORD SHS450,000$4.59M0.1%00.0%UnchangedHistory
TARAProtara Therapeutics, Inc.COM STK421,641$4.11M0.1%−10.0%ReducedHistory
MRUSMerus N.V.COM175,000$3.69M<0.1%00.0%UnchangedHistory
AMWLAmerican Well CorpCL A290,000$3.65M<0.1%−65,000−18.3%ReducedHistory
RGNXREGENXBIO Inc.COM89,283$3.47M<0.1%+20,000+28.9%AddedHistory
CM Life Sciences Inc18978W109COM CL A227,000$3.18M<0.1%+100,000+78.7%Added–
FULCFulcrum Therapeutics, Inc.COM294,118$3.08M<0.1%+294,118NewHistory
SNCEScience 37 Holdings, Inc.COM300,000$3.00M<0.1%00.0%UnchangedHistory
GRTXGalera Therapeutics, Inc.COM254,664$2.50M<0.1%00.0%UnchangedHistory
KRROKorro Bio, Inc.COM222,222$2.21M<0.1%−1,891,439−89.5%ReducedHistory
Cerevel Therapeutics HLDNG I15678U102*W EXP 06/09/202133,066$1.91M<0.1%00.0%Unchanged–
MOTSMotus GI Holdings, Inc.COM1,800,542$1.87M<0.1%00.0%UnchangedHistory
SGTXSigilon Therapeutics, Inc.COM125,000$1.34M<0.1%00.0%UnchangedHistory
SRRASierra Oncology, Inc.COM NEW66,655$1.30M<0.1%00.0%UnchangedHistory
RACEFerrari N.V.COM6,200$1.28M<0.1%00.0%UnchangedHistory
EIGREiger BioPharmaceuticals, Inc.COM139,890$1.19M<0.1%00.0%UnchangedHistory
Butterfly Network, Inc.124155110*W EXP 05/27/202233,333$1.13M<0.1%00.0%Unchanged–
SC Health CorpG78516401*W EXP 99/99/999500,000$1.05M<0.1%00.0%Unchanged–
PLXPPLx Pharma Winddown Corp.COM57,459$793.0K<0.1%−164,721−74.1%ReducedHistory
TKNOAlpha Teknova, Inc.COM30,000$712.0K<0.1%+30,000NewHistory
TCRRTCR2 Therapeutics Inc.COM30,753$505.0K<0.1%−282,547−90.2%ReducedHistory
PHVSPharvaris N.V.COM27,000$503.0K<0.1%00.0%UnchangedHistory
CareMax, Inc.14171W111*W EXP 06/08/20260,000$283.0K<0.1%+60,000New–

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q2 2021
SecurityClassPutsCalls
TDOCTeladoc Health, Inc.COM–$16.6M
RAPTRAPT Therapeutics, Inc.COM$83.0K–

Sold out since Q1 2021 (17)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
ALLOAllogene Therapeutics, Inc.COM1,143,790$40.4M0.5%History
ARNAArena Pharmaceuticals IncCOM NEW575,007$39.9M0.5%History
ACADAcadia Pharmaceuticals IncCOM1,410,305$36.4M0.5%History
FMTXForma Therapeutics Holdings, Inc.SHS1,250,000$35.0M0.5%History
CMPSCOMPASS Pathways plcSPONSORED ADS797,404$29.4M0.4%History
PCVXVaxcyte, Inc.COM850,000$16.8M0.2%History
SNDXSyndax Pharmaceuticals IncCOM270,000$6.04M0.1%History
VINCVincerx Pharma, Inc.COM NEW300,000$5.79M0.1%History
PHRPhreesia, Inc.COM100,000$5.21M0.1%History
Deerfield Healthcare Tech Ac244413209UNIT 07/16/2025300,000$3.93M0.1%–
TXMDTherapeuticsMD, Inc.COM2,750,000$3.69M<0.1%History
VRAYViewRay, Inc.COM751,748$3.27M<0.1%History
TLISTalis Biomedical CorpCOM250,000$3.21M<0.1%History
Vincerx Pharma, Inc.92731L114*W EXP 12/24/202300,000$1.21M<0.1%–
CVMCel Sci CorpCOM PAR NEW33,700$513.0K<0.1%History
SANASana Biotechnology, Inc.COM10,000$335.0K<0.1%History
Deerfield Healthcare Tech Ac244413100COM CL A20,000$242.0K<0.1%–